Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-01-25FDA Approved: RECLAST — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for RECLAST (zoledronic acid) filed by Sandoz Inc.
-
FDA approval · 2011-01-14FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triporelin pamoate) filed by Verity Pharmaceuticals Inc.
-
FDA approval · 2011-01-14FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) submitted by Verity Pharmaceuticals Inc. This action updates …
-
FDA approval · 2010-10-05FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) by URONOVA PHARMACEUTICALS, INC.
-
FDA approval · 2010-09-15FDA Approved: CASODEX — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CASODEX (bicalutamide) filed by ANI Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-09-15FDA Approved: BICALUTAMIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for bicalutamide by Accord Healthcare Inc., authorizing changes to its approved labeling.
-
FDA approval · 2009-07-06FDA Approved: BICALUTAMIDE — Original Application (Viona Pharmaceuticals Inc.)
FDA approved an original application for generic bicalutamide from Viona Pharmaceuticals Inc., authorizing the sale of the generic product.
-
FDA approval · 2009-07-06FDA Approved: BICALUTAMIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's generic bicalutamide through an original ANDA, providing a generic antiandrogen option for prostate cancer…
-
FDA approval · 2009-07-06FDA Approved: BICALUTAMIDE — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare's original application for a generic version of bicalutamide. Bicalutamide is used in the treatment of ad…
-
FDA approval · 2009-03-13FDA Approved: CASODEX — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental application for Casodex (bicalutamide), indicating an approved change to the product's labeli…
-
FDA approval · 2009-03-09FDA Approved: LEUPROLIDE ACETATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Leuprolide acetate from Sun Pharmaceutical Industries as an original application (generic) for multiple hormone-related indicat…
-
FDA approval · 2008-12-24FDA Approved: FIRMAGON — Original Application (Ferring Pharmaceuticals Inc.)
The FDA approved Firmagon (degarelix) through an original application for the treatment of advanced prostate cancer. The drug is manufacture…
-
FDA approval · 2008-04-14FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc. The action approves changes asso…
-
FDA approval · 2008-04-14FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) submitted by Verity Pharmaceuticals Inc. The approval pertains to…
-
FDA approval · 2007-11-08FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA PHARMACEUTICALS, INC., signaling an expanded/updated …
-
FDA approval · 2007-02-16FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triporelin pamoate) from Verity Pharmaceuticals Inc.